Hydantoin derivative-containing pharmaceutical composition
US9993462B2 · kind B2 · utility
0Cited by
7References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 2014 |
| Grant date | Jun 12, 2018 |
| Priority date | — |
| Expiry date | Jun 9, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides pharmaceutical compositions for inducing bone and/or cartilage anabolism, which comprises as an active ingredient a compound represented by formula (1) below and a pharmacologically acceptable salt thereof: wherein R1, R2, R3, and R4 are as defined in the claims.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.